Abrupt cuts by the Trump administration to the US National Institutes of Health threaten progress in medical research ...

After Gilead Sciences' lenacapavir made waves with stellar clinical results as a twice-yearly HIV prevention candidate, the ...

Takeda Pharmaceutical has a robust drug discovery pipeline to meet future clinical demand. Check out the upside and downside ...

Topiramate, which is also an anti-seizure medicine, is currently the only US Food and Drug Administration (FDA) medication ...

Sutro Biopharma is undergoing a seismic shake-up —jettisoning its CEO, half of its workforce, its lead candidate and its ...

Shri Amit Agrawal highlighted the rapid expansion of the sector, emphasizing India’s growing role in research and innovation.

Sutro’s stock tumbled nearly 19% after the company announced it will sideline its FRα-targeted antibody-drug conjugate ...

Sutro will rapidly advance next-generation exatecan and dual-payload ADC programs; luveltamab tazevibulin development to be deprioritized as ...

As health care costs continue to rise and the burden of chronic disease grows, data-driven insights will be essential in ...

Most guidance for management of hypercholesterolemia apply across patient demographics and characteristics. However, there ...